Please enable JS

About Us

FOUNDERS & SCIENTIFIC ADVISORS

CRISPR Therapeutics was founded by Rodger Novak, Emmanuelle Charpentier and Shaun Foy in November 2013 with initial funding from Versant Ventures and the mission of developing gene-editing based therapeutics for serious diseases. The company was established in Basel, Switzerland and subsequently opened R&D operations in Cambridge, Massachusetts. After formation of the company, the founding team was expanded to include leading scientists with diverse expertise as scientific advisors. Our team is comprised of experts in fields such as CRISPR/Cas9 and other systems for gene editing, stem cell biology, advanced drug delivery technologies, RNA interference and gene silencing.
 

DR. RODGER NOVAK
Founder and CEO
DR. EMMANUELLE CHARPENTIER
Founder and Scientific Advisory Board Member
SHAUN FOY
Founder
DR. CHAD COWAN
Scientific Founder and Head of Research
DR. DANIEL ANDERSON
Scientific Founder and Advisory Board Member
DR. STEPHEN ELLEDGE
Scientific Advisory Board Member
DR. CRAIG MELLO
Scientific Founder and Advisory Board Member
DR. MATTHEW PORTEUS
Scientific Founder and Advisory Board Member